Turkey
Bilim İlaç, founded in 1953, is a prominent player in Turkey's pharmaceutical industry, ranking third among the country's 300 pharmaceutical companies. Operating entirely with Turkish capital, the company has consistently demonstrated market-leading performance in the strategic domain of drug production and marketing.
The company operates two state-of-the-art facilities: the Bilim Çerkezköy, approved by the German Ministry of Health, is one of Turkey's key penicillin production sites. Meanwhile, the Bilim Gebze facility, approved by the UK Ministry of Health, stands as Turkey’s largest and most environmentally conscious drug manufacturing plant.
Bilim İlaç boasts a substantial 4,500 square meter R&D center, the largest in the Turkish pharmaceutical sector, contributing significantly to the national economy with innovative products. Internationally, they export to over 50 countries and maintain offices in Moldova, Georgia, Bosnia and Herzegovina, and Albania.
The company is deeply committed to quality and sustainability in healthcare, ensuring their operations and values align with respect for future generations.
